Evidence map›Paper›PMID 40746731›Full record

ArticleFrontiers in pharmacology2025

Biological potential of

Alfredo Torres-Benítez, José Erick Ortega-Valencia, Juan Rodrigo Salazar, Jaqueline Ley-Martínez, Javian Gallardo-Valdivia, Marta Sánchez, María Pilar Gómez-Serranillos, Gabriel Vargas-Arana, Mario J Simirgiotis

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alfredo Torres-BenítezCarrera de Química y Farmacia, Facultad de Ciencias, Universidad San Sebastián, Valdivia, Chile.
José Erick Ortega-ValenciaTecnológico Nacional de México-Instituto Tecnológico Superior de Xalapa, Veracruz, Mexico.
Juan Rodrigo SalazarDepartamento de Sistemas Biológicos, División de Ciencias Biológicas y de la Salud, Universidad Autónoma Metropolitana, Mexico City, Mexico.
Jaqueline Ley-MartínezTecnológico Nacional de México-Instituto Tecnológico Superior de Xalapa, Veracruz, Mexico.
Javian Gallardo-ValdiviaLaboratorio Biología de Plantas, Facultad de Ciencias Forestales y Conservación de la Naturaleza, Universidad de Chile, Santiago, Chile.
Marta SánchezDepartamento de Farmacología, Farmacognosia y Botánica, Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, Spain.
María Pilar Gómez-SerranillosDepartamento de Farmacología, Farmacognosia y Botánica, Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, Spain.
Gabriel Vargas-AranaLaboratorio de Química de Productos Naturales, Instituto de Investigaciones de la Amazonía Peruana, Iquitos, Peru.
Mario J SimirgiotisInstituto de Farmacia, Facultad de Ciencias, Universidad Austral de Chile, Campus Isla Teja, Valdivia, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antioxidant potentialenzymatic inhibitionextractfernlophosoriametabolitesNrf2-Keap1 signaling pathway

Identifiers

PMID40746731
PMCPMC12311474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.